Neutrophil gelatinase-associated lipocalin (Ngal, 24p3, SIP24, lipocalin 2 or siderocalin) was originally purified from neutrophils but with unkown function. Recently, it was identified that Ngal activates nephron formation in the embryonic kidney, is rapidly and massively induced in renal failure and possesses kidney protective activity. We would like to propose that blood, urine and kidney Ngal levels are the real-time indicators of active kidney damage, rather than one of many markers of functional nephron number (as Forest Fire Theory). Ngal is a novel iron carrier protein exerting pleiotropic actions including the upregulation of epithelial marker E-cadherin expression, opening an exciting field in cell biology.
resulting in protection against atherosclerosis. 3 Mice with a null mutation in adipocyte fatty acid-binding protein (FABP4 or adipocyte protein aP2) become obese under high-fat diet but do not develop insulin resistance. 4 Little is known about the involvement of the ligands in these metabolic activities of lipocalins. Goetz Ngal protein expressed in E. coli. 5 They demonstrated that the ligand for Ngal is siderophore. Siderophores are a diverse group of small (1kDa or less) non-peptide iron (Fe 3+ )-binding chemicals produced in bacteria, fungi and plants, and their mammalian version remains to be identified. [6] [7] [8] [9] Of note, XL1-Blue strain of E. coli synthesizes a siderophore called enterochelin (or enterobactin), but BL21 commonly used for recombinant protein expression does not make enterochelin. 5 Probably outside the pocket, Ngal binds with gelatinase B (matrix metalloproteinase-9 or type IV collagenase) and with hepatocyte growth factor and modulates their activity. [10] [11] [12] 
NGAL IN KIDNEY DEVELOPMENT
Mammalian metanephric mesenchyme and ureteric bud (UB) coordinate a complicated interaction to develop themselves into mature nephrons. 13 Barasch et al. established an organ culture system where isolated rat metanephric mesenchyme converts into glomeruli and proximal tubules by stimulation with condition media prepared from a mouse UB cell line. 14 Leukemia inhibitory factor (LIF) and Ngal were the epithelial inducers purified at the protein level using this assay. 14, 15 shown that mouse Ngal protein secreted from cultured UB cells possesses nephron-inducing activity and also can bind iron. 15 Surprisingly, Ngal:bacterial siderophore:iron complex has much stronger activity compared to Ngal:siderophore (without iron) and apo-Ngal (without siderophore), 17 indicating the first example of "siderophore-binding proteins," in any species, dependent upon the presence of iron for ischemia-reperfusion compared to wild-type mice. 24 Although Ngal mRNA upregulation minireview K Mori and K Nakao: Ngal and renal failure -5is a rapid response, the speed and amount of endogenous Ngal induction may not be sufficient to show significant protection in this setting. Experiments in more chronic and milder models may give different results.
TRANSCRIPTIONAL REGULATION OF NGAL
Neutrophils, 25 monocytes/macrophages 26 and adipocytes 27 are cells with abundant Ngal expression ( Figure 3 ). Importantly, immature neutrophils (myelocytes and metamyelocytes) have high expression level of Ngal mRNA, while mature neutrophils/granulocytes in the circulation have lost the mRNA but contain large amount of Ngal protein, 25 making it impossible to determine the involvement of neutrophil-dereived Ngal in tissue injury by in situ mRNA hybridization. Ngal expression is highly induced not only in kidney injury, but also in epithelial inflammation of intestine, 28 skin and airway, 29 and in bacterial infection 16 and cancer. 30 Ngal inducers so far identified in vitro are interleukin-1 beta, tissue necrosis factor alpha, lipopolysaccharide, basic fibroblast growth factor, prostaglandin F2 alpha, phorbol ester, dexamethasone, retinoic acid, serum and hypoxia. 20, 26, 29, 31 
BIOLOGICAL ACTIVITY OF NGAL
Ngal exerts a broad range of biological activities (Figure 3 ). The co-existence of siderophore and iron is required not only for mesenchymal-epithelial transition (MET) of embryonic kidney 17 
and oncogene Ras-transformed epithelial cells (by Hanai and
Sukhatme et al.) 30 but also for kidney protection from renal failure (by Mori et al.). 9 On the other hand, Ngal:siderophore complex without iron 17 (and potentially apo-Ngal) 32 can chelate iron from cells and iron deprivation is the mechanism for apoptosis of pro-B cells, 32, 33 and for inhibition of bacterial growth and erythropoiesis. 5, 16, 34 Various other activities of Ngal are increasingly reported. 12, 28 Induction of MET by Ngal is associated with upregulation of epithelial marker E-cadherin expression, but this is a slow process. In metanephric mesenchyme, morphologically distinct epithelia is observed only 7-10 days after addition of Ngal:siderophore:iron complex (unpublished observation). 15 By contrast, epithelia induced by LIF can be observed within 4-5 days. 13, 14 In Ras-transformed mammary cells, E-cadherin protein accumulation was evaluated 48 hours after treatment with the complex. 30 are not necessarily parallel with the severity of renal injury, 35 suggesting that suppression of this pathway is not the major mechanism for Ngal-mediated kidney protection. Administration of Ngal is ineffective if given 2 hours after reperfusion, 9 implying that Ngal is preventing the early injuries (in part by upregulating a protective enzyme heme oxygenase-1) 9 rather than stimulating the recovery process.
In healthy adult kidneys, Ngal 36 and other lipocalins (whose sizes are 17-43 kDa) including retinol-binding protein 4, alpha 1-microglobulin, 37 and probably also liver-type fatty acid-binding protein (FABP1) and PGDS are freely filtrated in the glomeruli, bound to multi-ligand scavenger receptor megalin (expressed abundantly and specifically on the brush borders of proximal tubules) and taken up efficiently by endocytosis (as well as albumin and beta 2-microglobulin). 38 Iron-free siderophore-like activity (which assists the binding of Ngal and Fe 3+ )
is detectable in the normal urine of humans, mice, rats and dogs. 9, 39 Tear lipocalin, a major protein component especifically found in human tears, also binds with siderophores. 40 Lipocalin 12, found specifically in mouse epididymis, is also structurally related to Ngal and may have binding capacity for siderophores. 41
CHARACTERISTICS OF NGAL AS RENAL FAILURE BIOMARKER
Ngal induction is a rapid event detectable within a few hours, characterizing Ngal as one of immediate early genes or acute phase reactants such as interleukin-6 and C-reactive protein. Fold induction of Ngal mRNA and protein is log order of magnitude, reaching 1000-fold in most severe cases of renal injury. 9, 39 Therefore, normalization for urinary creatinine level is not necessary to evaluate urinary Ngal. 21 
DIRECTIONS FOR FUTURE RESEARCH
There are a number of siderohpre-dependent and -independent activities reported for
Ngal. The role of endogenously expressed Ngal in these activities should be better verified using Ngal deficient mice. During renal ischemia-reperfusion injury, the liver also starts to express Ngal mRNA. 39 Therefore, the source of Ngal protein in the blood and urine during renal injury can be a complex from the kidney, liver and white blood cells (in the injured tissues and in the circulation). Tissue-specific disruption of Ngal gene will make it possible to investigate what is the predominant source of Ngal, as a biomarker or as a protective mechanism for renal failure. Purification and identification of mammalian siderophores, and to learn their metabolism and regulation are also important steps. The reported method to recognize siderophores is only available for iron-free molecules. 9 A new way to detect iron-loaded siderophores must be invented.
Characterization of Ngal receptors, their downstream intracellular signaling and subcellular localization of events will help elucidate the detailed molecular mechanism underlying the actions of Ngal, siderophores and iron.
CONCLUSION
Ngal is a very unique protein endowed with iron carrying activity and diagnostic and therapeutic utilities for renal failure, which is acquiring an explosion of attention by researchers and clinicians beyond nephrology. 
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